Unknown

Dataset Information

0

Abrogation of Marek's disease virus replication using CRISPR/Cas9.


ABSTRACT: Marek's disease virus (MDV) is a highly cell-associated alphaherpesvirus that causes deadly lymphomas in chickens. While vaccination protects against clinical symptoms, MDV field strains can still circulate in vaccinated flocks and continuously evolve towards greater virulence. MDV vaccines do not provide sterilizing immunity, allowing the virus to overcome vaccine protection, and has increased the need for more potent vaccines or alternative interventions. In this study, we addressed if the CRISPR/Cas9 system can protect cells from MDV replication. We first screened a number of guide RNAs (gRNAs) targeting essential MDV genes for their ability to prevent virus replication. Single gRNAs significantly inhibited virus replication, but could result in the emergence of escape mutants. Strikingly, combining two or more gRNAs completely abrogated virus replication and no escape mutants were observed upon serial passaging. Our study provides the first proof-of-concept, demonstrating that the CRISPR/Cas9 system can be efficiently used to block MDV replication. The presented findings lay the foundation for future research to completely protect chickens from this deadly pathogen.

SUBMITTER: Hagag IT 

PROVIDER: S-EPMC7331644 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Abrogation of Marek's disease virus replication using CRISPR/Cas9.

Hagag Ibrahim T IT   Wight Darren J DJ   Bartsch Denise D   Sid Hicham H   Jordan Ingo I   Bertzbach Luca D LD   Schusser Benjamin B   Kaufer Benedikt B BB  

Scientific reports 20200702 1


Marek's disease virus (MDV) is a highly cell-associated alphaherpesvirus that causes deadly lymphomas in chickens. While vaccination protects against clinical symptoms, MDV field strains can still circulate in vaccinated flocks and continuously evolve towards greater virulence. MDV vaccines do not provide sterilizing immunity, allowing the virus to overcome vaccine protection, and has increased the need for more potent vaccines or alternative interventions. In this study, we addressed if the CRI  ...[more]

Similar Datasets

| S-EPMC7340974 | biostudies-literature
| S-EPMC7232411 | biostudies-literature
| S-EPMC6563304 | biostudies-literature
| S-EPMC8482593 | biostudies-literature
| S-EPMC7576162 | biostudies-literature
| S-EPMC6997755 | biostudies-literature
| S-EPMC7005665 | biostudies-literature
| S-EPMC9304932 | biostudies-literature
| S-EPMC4786927 | biostudies-literature
| S-EPMC5939577 | biostudies-literature